Global Nutraceutical CDMO Market Size & Trends Report Segmented by Dosage Form (Tablets, Softgel, Powder), Service Type (Product Formulation & Development, R&D, Manufacturing), Company Size (Small, Mid-Size, Large), & Regional Forecast to 2030
The nutraceutical CDMO market is anticipated to expand at a CAGR of ~8% during the forecast period. Key drivers of this growth include rising demand for nutraceutical products, technological advancements in manufacturing, shift towards plant-based and ayurvedic supplements, expanding nutraceutical applications, growing outsourcing trends in the nutraceutical industry, adoption of sedentary lifestyle & rising aging population, and increasing consumer focus on wellness and personalized nutrition. To learn more about the research report, download a sample report.
Report Overview
A nutraceutical CDMO (Contract Development and Manufacturing Organization) is a company that provides outsourced services for the development, formulation, manufacturing, and packaging of nutraceutical products on behalf of brand owners and health supplement companies. 
To learn more about the research report, download a sample report.
Rising demand for nutraceutical products driving the growth of the nutraceutical CDMO market
Nutraceutical products encompass a wide range of substances and food items that offer medical or health benefits beyond basic nutrition, aiming to support disease prevention and treatment. As dietary habits evolve, the demand for these products continues to rise, driven by increasing consumer awareness, the growing prevalence of non-communicable diseases, and escalating healthcare costs. Additionally, the consumption of multivitamins is expected to surge as consumers prioritize immune system support, a trend that gained significant momentum during the COVID-19 pandemic and is likely to persist in the future. To meet these shifting consumer demands, nutraceutical companies are increasingly partnering with CDMOs for cost-effective, large-scale production, advanced R&D capabilities, and regulatory compliance. With stringent FDA and global regulations, CDMOs provide essential expertise in quality assurance, labeling, and clinical trials, ensuring that brands deliver high-quality, compliant products to market. The rapid expansion of e-commerce and direct-to-consumer (DTC) brands has further accelerated the need for private-label manufacturing and turnkey solutions. As the nutraceutical industry continues its rapid growth, CDMOs play a vital role in helping brands scale efficiently, develop innovative formulations, and cater to the increasing consumer demand for health and wellness solutions. 
To learn more about the research report, download a sample report.
Growing outsourcing trends in the nutraceutical industry fuel its demand
Nutraceuticals and dietary ingredients such as probiotics, folic acid, and fish oil offer significant health benefits, including supporting biological processes that help prevent chronic diseases, promoting healthy aging, and maintaining the body's structure and function. As nutraceutical companies capitalize on this growing market, many are turning to specialized CDMOs with expertise in fine chemicals. CDMOs provide end-to-end solutions, including R&D, formulation, raw material sourcing, production, packaging, and labeling, allowing companies to focus on branding, marketing, and distribution while outsourcing manufacturing complexities. This approach helps streamline production, reduce costs, and enhance product quality while ensuring compliance with industry regulations. Key ways CDMOs support the growth of nutraceutical companies include reduced capital investment, regulatory compliance expertise, advanced manufacturing capabilities, and efficient development cycles.
Competitive Landscape Analysis
The global nutraceutical CDMO market is marked by the presence of established and emerging market players such as Catalent Inc.; Lonza; NutraScience Labs; Robinson Pharma, Inc.; Health Wright Products, Inc.; INPHARMA S.p.A.; Aenova Group; NutraPakUSA; SFI Health; Eurofins; WuXi AppTec; and Charles River Laboratories; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and investments.
Report Scope
| Report Scope | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 - 2030 |
| Growth Rate | ~8% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Dosage Form, Service Type, and Company Size |
| Regional Scope |
|
| Key Companies Mapped | Catalent Inc.; Lonza; NutraScience Labs; Robinson Pharma, Inc.; Health Wright Products, Inc.; INPHARMA S.p.A.; Aenova Group; NutraPakUSA; SFI Health; Eurofins; WuXi AppTec; and Charles River Laboratories |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Market Segmentation
This report by Medi-Tech Insights provides the size of the global nutraceutical CDMO market at the regional- and country-level from 2023 to 2030. The report further segments the market based on dosage form, service type, and company size.
- Market Size & Forecast (2023-2030), By Dosage Form, USD Million
- Tablets & Capsules
- Softgel
- Powder
- Others
- Market Size & Forecast (2023-2030), By Service Type, USD Million
- Product Formulation and Development
- Research & Development (R&D)
- Manufacturing and Packaging
- Regulatory Compliance
- Others
- Market Size & Forecast (2023-2030), By Company Size, USD Million
- Small Companies
- Mid-Sized Companies
- Large Companies
- Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
- North America
Key Strategic Questions Addressed
- What is the market size & forecast of the nutraceutical CDMO market?
- What are the historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the nutraceutical CDMO market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Nutraceutical CDMO Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Rising demand for nutraceutical products
- Technological advancements in manufacturing
- Shift towards plant-based and ayurvedic supplements
- Expanding nutraceutical applications
- Growing outsourcing trends in the nutraceutical industry
- Increasing consumer focus on wellness and personalized nutrition
- Restraints
- High manufacturing and R&D costs
- Threat of counterfeit dietary supplements
- Stringent regulatory and compliance requirements
- Opportunities
- Growing demand for personalized nutrition
- Increasing demand for high-protein supplements and endurance-boosting formulations in sports nutrition
- Rising consumer interest in functional foods & beverages
- Key Market Trends
- Adoption of AI and automation in nutraceutical development/manufacturing
- Growing trend towards plant-based and non-GMO nutraceuticals
- Strategic collaborations & partnerships between pharmaceutical companies and CDMOs
- Unmet Market Needs
- Industry Speaks
- Global Nutraceutical CDMO Market Size & Forecast (2023-2030), By Dosage Form, USD Million
- Introduction
- Tablets & Capsules
- Softgel
- Powder
- Others
- Global Nutraceutical CDMO Market Size & Forecast (2023-2030), By Service Type, USD Million
- Introduction
- Product Formulation and Development
- Research & Development (R&D)
- Manufacturing and Packaging
- Regulatory Compliance
- Others
- Global Nutraceutical CDMO Market Size & Forecast (2023-2030), By Company Size, USD Million
- Introduction
- Small Companies
- Mid-Sized Companies
- Large Companies
- Global Nutraceutical CDMO Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Nutraceutical CDMO Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Dosage Form (USD Million)
- Market Size & Forecast, By Service Type (USD Million)
- Market Size & Forecast, By Company Size (USD Million)
- Canada
- Market Size & Forecast, By Dosage Form (USD Million)
- Market Size & Forecast, By Service Type (USD Million)
- Market Size & Forecast, By Company Size (USD Million)
- US
- Europe Nutraceutical CDMO Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Dosage Form (USD Million)
- Market Size & Forecast, By Service Type (USD Million)
- Market Size & Forecast, By Company Size (USD Million)
- Germany
- Market Size & Forecast, By Dosage Form (USD Million)
- Market Size & Forecast, By Service Type (USD Million)
- Market Size & Forecast, By Company Size (USD Million)
- France
- Market Size & Forecast, By Dosage Form (USD Million)
- Market Size & Forecast, By Service Type (USD Million)
- Market Size & Forecast, By Company Size (USD Million)
- Italy
- Market Size & Forecast, By Dosage Form (USD Million)
- Market Size & Forecast, By Service Type (USD Million)
- Market Size & Forecast, By Company Size (USD Million)
- Spain
- Market Size & Forecast, By Dosage Form (USD Million)
- Market Size & Forecast, By Service Type (USD Million)
- Market Size & Forecast, By Company Size (USD Million)
- Rest of Europe
- Market Size & Forecast, By Dosage Form (USD Million)
- Market Size & Forecast, By Service Type (USD Million)
- Market Size & Forecast, By Company Size (USD Million)
- UK
- Asia Pacific (APAC) Nutraceutical CDMO Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Dosage Form (USD Million)
- Market Size & Forecast, By Service Type (USD Million)
- Market Size & Forecast, By Company Size (USD Million)
- Japan
- Market Size & Forecast, By Dosage Form (USD Million)
- Market Size & Forecast, By Service Type (USD Million)
- Market Size & Forecast, By Company Size (USD Million)
- India
- Market Size & Forecast, By Dosage Form (USD Million)
- Market Size & Forecast, By Service Type (USD Million)
- Market Size & Forecast, By Company Size (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Dosage Form (USD Million)
- Market Size & Forecast, By Service Type (USD Million)
- Market Size & Forecast, By Company Size (USD Million)
- China
- Latin America (LATAM) Nutraceutical CDMO Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Dosage Form (USD Million)
- Market Size & Forecast, By Service Type (USD Million)
- Market Size & Forecast, By Company Size (USD Million)
- Middle East & Africa (MEA) Nutraceutical CDMO Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Dosage Form (USD Million)
- Market Size & Forecast, By Service Type (USD Million)
- Market Size & Forecast, By Company Size (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Company Profiles* (Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Catalent Inc.
- Lonza
- NutraScience Labs
- Robinson Pharma, Inc.
- Health Wright Products, Inc.
- INPHARMA S.p.A.
- Aenova Group
- SFI Health
- Eurofins
- WuXi AppTec
- Other Prominent Players
- Key Players and their Competitive Positioning
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Pharmaceutical & Biotech Companies, Nutraceutical & Dietary Supplement Brands, Functional Food & Beverage Companies, Healthcare & Wellness Centers, and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts.
Data Triangulation
Research findings derived through secondary sources & internal analysis were validated with Primary Interviews, the Internal Knowledge Repository, and the Company’s Sales Data.
